Mucin Mimics and Impacts the Function of Polymeric Inhibitors in Stabilizing Drug Supersaturation
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.4c01102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Victus Kordorwu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, College of Engineering, Northeastern University, Boston, Massachusetts 02115, United States. Hauptthemen laut MEDLINE: Mucins, Polymers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Genentech, Northeastern University.
Abstract (Originalsprache)
Many drugs entering clinical trials today are poorly water-soluble and rely on supersaturating formulations, such as amorphous solid dispersions (ASD) to enhance their bioavailability. The in vivo performance of these formulations is often investigated through biorelevant dissolution testing using simulated intestinal fluid. Often overlooked in biorelevant dissolution is the presence of mucus within the intestinal environment and its possible role in affecting the formulation performance. In this study, the impact of mucins, the main structural glycoproteins of mucus, on the precipitation of two model compounds, carvedilol and nifedipine, from supersaturated solutions was investigated. The presence of mucin within the supersaturated environment was demonstrated to significantly alter the rate of drug precipitation in vitro. The impact of mucin on precipitation was then compared to commercially available polymer precipitation inhibitors hydroxypropyl methylcellulose (HPMC) and Kollidon VA 64, which are commonly used in ASD formulations. Surprisingly, when present at the same concentration (0.2% (w/v)), mucin reduces drug precipitation to an extent comparable to that of polymer precipitation inhibitors. Additionally, we observed that the presence of mucin in the supersaturated environment altered the precipitation inhibitory effects of HPMC and Kollidon VA64, suggesting that mucin could play an important and complicated role in formulation performance in the intestine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, College of Engineering, Northeastern University, Boston, Massachusetts 02115, United States.
- Small Molecule Pharmaceutical Sciences, Research and Early Development, Genentech Inc., South San Francisco, California 94080, United States.
ORCID-Profile: Victus Kordorwu
Förderung
- NIGMS NIH HHS
- Genentech
- Northeastern University
- National Institutes of Health
Zitieren
APA
Kordorwu, V., Castleberry, S., Lustig, S., & Carrier, R. L. (2025). Mucin Mimics and Impacts the Function of Polymeric Inhibitors in Stabilizing Drug Supersaturation. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01102
Vancouver
Kordorwu V, Castleberry S, Lustig S, Carrier RL. Mucin Mimics and Impacts the Function of Polymeric Inhibitors in Stabilizing Drug Supersaturation. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01102
BibTeX
@article{Kordorwu2025,
author = {Kordorwu, Victus and Castleberry, Steven and Lustig, Steve and Carrier, Rebecca L},
title = {Mucin Mimics and Impacts the Function of Polymeric Inhibitors in Stabilizing Drug Supersaturation},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.4c01102}
}
EUVIMED